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Abstract
Wheat is an important staple food and potent allergen source. Recently, we isolated a cDNA coding for wheat alpha-
purothionin which is recognized by wheat food allergic patients at risk for severe wheat-induced allergy. The purpose of the
present study was the biochemical, biophysical and IgE epitope characterization of recombinant alpha-purothionin.
Synthetic genes coding for alpha-purothionin were expressed in a prokaryotic system using Escherichia coli and in a
eukaryotic expression system based on baculovirus-infected Sf9-insect cells. Recombinant proteins were purified and
characterized by SDS-PAGE, mass spectrometry, circular dichroism, chemical cross-linking and size exclusion
chromatography. Five overlapping peptid were synthesized for epitope mapping. Alpha-purothionin-specific rabbit
antibodies were raised to perform IgE-inhibition experiments and to study the resistance to digestion. The IgE reactivity of
the proteins and peptides from ten wheat food allergic patients was studied in non-denaturing RAST-based binding assays.
Alpha-purothionin was expressed in the prokaryotic (EcTri a 37) and in the eukaryotic system (BvTri a 37) as a soluble and
monomeric protein. However, circular dichroism analysis revealed that EcTri a 37 was unfolded whereas BvTri a 37 was a
folded protein. Both proteins showed comparable IgE-reactivity and the epitope mapping revealed the presence of
sequential IgE epitopes in the N-terminal basic thionin domain (peptide1:KSCCRSTLGRNCYNLCRARGAQKLCAGVCR) and in
the C-terminal acidic extension domain (peptide3:KGFPKLALESNSDEPDTIEYCNLGCRSSVC, peptide4:CNLGCRSSVCDYMV-
NAAADDEEMKLYVEN). Natural Tri a 37 was digested under gastric conditions but resistant to duodenal digestion.
Immunization with EcTri a 37 induced IgG antibodies which recognized similar epitopes as IgE antibodies from allergic
patients and inhibited allergic patients’ IgE binding. Reactivity to Tri a 37 does not require a folded protein and the presence
of sequential IgE epitopes indicates that sensitization to alpha-purothionin occurs via the gut. Both allergens can be used
for in-vitro diagnosis of wheat food allergy. The induction of blocking IgG antibodies suggests the usefulness for
immunotherapy.
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Introduction
Wheat is one of the most important components of our daily
nutrition. It contains several essential dietary constituents such as
carbohydrates, fats, dietary fibers, minerals, proteins, vitamins and
water. [1] However, wheat also belongs to the most important
allergy-eliciting foods causing local manifestations as well as severe
systemic reactions. [2] In fact, in a population of wheat food
allergic children more than 50% had experienced anaphylaxis
upon wheat ingestion [3] and wheat has been reported as one of
the major food allergen sources involved in food-induced
anaphylaxis in a study analysing 1000 patients with food allergy.
[4] However, only a few allergen molecules have been identified to
be involved in severe allergy to wheat. Among the known wheat
food allergens, v5-gliadin (Tri a 19) [5], a/b-gliadins (Tri a 21) [6]
and HMW glutenin (Tri a 26) [7] have been described as markers
for wheat-dependent exercise-induced anaphylaxis. Furthermore,
LTP (lipid transfer protein; Tri a 14) [8] was reported to play an
important role in the development of wheat-induced anaphylaxis.
Very recently we identified a novel wheat food allergen, alpha
purothionin, which according to the allergen nomenclature system
was designated Tri a 37. In 20% of wheat food allergic patients we
found IgE reactivity to Tri a 37 which was associated with a four-
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fold increased risk of experiencing severe wheat-induced anaphy-
laxis. [9]
The latter finding suggested that Tri a 37 may be a true wheat
food allergen (class I food allergen). [9] Class I food allergens
usually contain sequential epitopes and sensitization occurs mainly
via the gastrointestinal tract. [10,11] The wheat allergens v5-
gliadin, the HMW glutenins [7,12] as well as allergens from other
food allergen sources, such as egg (ovomucoid) [13] and cow’s milk
(alpha-, beta-casein) are examples for class I food allergens. [14]
Here we report the recombinant expression of Tri a 37 in a
prokaryotic system using Escherichia coli cells (EcTri a 37) and in
an eukaryotic system (baculovirus infected insect cells - BvTri a 37)
which yielded an unfolded and a folded form of Tri a 37 and thus
allowed us to study the potential relevance of conformational IgE
epitopes. Both allergens were characterized regarding biochemical
and biophysical properties. A detailed IgE epitope mapping of Tri
a 37 was performed with synthetic peptides spanning the complete
Tri a 37 sequence. Furthermore, we raised a rabbit antiserum
against Tri a 37 to study the natural Tri a 37 under conditions of
gastric and duodenal digestion in wheat extract and performed
IgE-inhibition experiments to investigate the protective activity of
IgG antibodies induced by immunization with Tri a 37.
Materials and Methods
Recombinant production of EcTri a 37
The cDNA coding for the mature Tri a 37 with a 39 sequence
coding for a hexahistidine tag was produced as synthetic gene with
codons optimized for expression in E.coli and subcloned into the
pET17b expression vector (ATG-biosynthetics, Merzhausen,
Germany). The recombinant allergen was then expressed in E.coli
BL21 (DE3) cells and purified by nickel affinity chromatography
from the inclusion body fraction (Quiagen, Hilden, Germany).
[15] The purified recombinant allergen EcTri a 37 was eluted
from the column in 8 M urea, 100 mM NaH2PO4, 10 mM Tris,
pH 4.6, then dialyzed step-wise against 10 mM NaH2PO4 buffer
pH 4.0 in which it remained soluble up to 2 mg/ml and could be
stored at 220uC. Specific rabbit antibodies against alpha
purothionin were raised by immunization of a New Zealand
white rabbit with purified EcTri a 37 (200 mg per injection) using
once Freund’s complete adjuvant and twice Freund’s incomplete
adjuvant. (Charles River, Kisslegg, Germany). Pre-immune serum
was obtained from the rabbit before immunization.
Recombinant production of BvTri a 37
Subcloning of Tri a 37 and production of recombinant
bacmid DNA. The cDNA (364 bp) coding for Tri a 37
(accession number AFQ60540.1) containing an additional 39
sequence coding for a hexahistidine tag was produced as synthetic
gene and subcloned into the BamHI/SmaI sites of pUC57
(GenScript, NJ, USA) with codons optimized for insect cell
expression. This cDNA was then cloned into the BamHI/SmaI
sites of the pTM1 vector harbouring the baculoviral polyhedrin
promoter sequence. [16] The plasmid containing the Tri a 37
insert was transformed into XL-1 Blue competent cells (Agilent
technologies, Santa Clara, USA) and selected for ampicillin and
tetracycline. The correct insertion of the cDNA was confirmed by
restriction analysis of plasmid mini-prep DNA (Promega, Madi-
son, Wisconsin, USA) with BamHI/SmaI and by sequence
analysis (VBC Biotech, Vienna, Austria). Following the manual
instructions (Version A, 15 December 2008) of the Bac-to-Bac
TOPO Expression System (Life Technologies, Carlsbad, CA,
USA), the recombinant donor plasmid containing the proper
DNA sequence was transformed into competent DH10Bac E.coli
cells, which allow the transposition of the DNA of interest into a
baculoviral bacmid. Using blue/white selection and screening for
resistance to kanamycin, tetracycline (ROTH, Karlsruhe, Ger-
many) and gentamicin (Life Technologies, Carlsbad, CA, USA)
colonies containing the Tri a 37 insert within the bacmid DNA
were identified. The presence of the correct recombinant bacmid
DNA containing the Tri a 37 gene was confirmed by PCR
analysis. A white colony was inoculated in 100 ml water and
heated for 5 min at 95uC. PCR analysis was performed using M13
primers (VBC Genomics) and GoTaq DNA polymerase (Promega,
Madison, Wisconsin, USA). After midi-prep (Promega) of a
positive overnight culture, occurrence of the correct DNA insert
was again confirmed by PCR.
Production of recombinant baculovirus, determination of
viral titer. Recombinant baculovirus was produced using the
Bac-to-Bac insect cell expression system (Life Technologies). The
recombinant bacmid DNA containing the Tri a 37 DNA was
transfected into Sf9 insect cells (Life Technologies) in order to
produce recombinant baculovirus. Sf9 insect cells were grown in
Sf-900 II SFM media (Life Technologies) supplemented with
10 mg/ml gentamicin (Life Technologies), 2.5% Fetal Bovine
Serum (Life Technologies) and maintained in the log phase
(36105–36106 cells/ml) at 27uC for the entire experiment. For
transfection, a total of 26106 Sf9 insect cells in 2 ml media per
well were seeded in a 6-well-plate and incubated for 30 min at
27uC for cell attachment. After replacing the medium containing
gentamicin and fetal bovine serum with medium, 100 ml
transfection cocktail consisting of 6 ml transfection reagent
(FuGENE HD Transfection Reagent, Promega, Madison), 2 mg
recombinant bacmid DNA, H2O ad 100 +l were added to each
well. After 7hrs, the medium was removed, replaced with fresh
medium containing gentamicin and FBS and incubated for 72hrs
at 27uC. Baculoviral stock (P1 viral stock) was collected from the
supernatant after centrifugation at 750 xrpm for 5 min at room
temperature and stored at 4uC in the dark until use. To determine
the viral titre, a plaque assay was performed seeding 2 ml of Sf9
cells (16106 Sf9 cells/well) in 6-well-plates for 1 hour. After
removing medium from the cells, attached insect cells were
infected with 1 ml/well of serial viral dilutions (P1: 104, 105, 106;
P2 and P3: 105, 106, 107, 108), using 1xDPBS (Life Technologies,
Carlsbad, CA, USA), for 1 hour at room temperature. The
supernatant was removed and infected insect cells were covered
with 2 ml of Sf-900 medium 1.3X (Life Technologies) containing
1% low-melting agarose and 10 mg/ml of gentamicin. Plates were
kept, without moving, for 1 hour at room temperature allowing the
agarose mixture to solidify. After wrapping the plate in moistur-
ized paper, the plate was covered with aluminium foil and
incubated for 5–7 days at 27uC. Plaques were stained with 2 ml of
neutral red solution (Sigma Aldrich, Munich, Germany), diluted
1:10 in 1xPBS for 2 hours at room temperature. After removal of
the staining solution, plaques became visible and were counted.
For further amplification of P1 stock to generate a high-titer P2
stock, the following formula was used: inoculum required (ml) =
[MOI (pfu/cell) x number of cells]/titer of viral stock (pfu/ml).
Ten ml of cells (26106 cells/mlR 26107 cells) were infected with
2 ml of P1 stock (16106 pfu/ml) to obtain a MOI (multiplicity of
infection: number of virus particles per cell) of 0.1. The viral titer
of P2 stock was again determined by plaque assay and stored as
described above for P1 viral stock.
In optimization experiments, several conditions (MOI 1, 2, 3, 4;
durations of expression 24hrs, 48hrs, 72hrs, 96hrs) were tested to
optimize the protocol. Samples were taken, centrifuged at
10,000 rpm for 2 min, sample buffer was added to the superna-
tants and stored at 4uC. All collected samples were subjected to
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14% SDS-PAGE, blotted onto nitrocellulose and tested with Tri a
37-specific rabbit antibodies to detect the level of BvTri a 37
expression.
Expression of BvTri a 37. For expression of BvTri a 37,
200 ml of 26106 cells/ml Sf9 cells present in fresh Sf-900 II SFM
medium (+Gm, -FBS) were infected with the viral P2 stock to
reach MOI=1 for 96hrs while shaking at 80 rpm/min at 27uC in
the dark. After centrifugation at 750 xrpm for 15 min, PMSF
(10 mg/ml) were added to secreted protein-containing superna-
tants. For protein purification under native conditions, using nickel
affinity chromatography (Qiagen), supernatants were dialyzed
against lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 1 mM
Imidazole, pH 8.0) o/N, and incubated with pre-equilibrated
nickel agarose in a batch procedure o/N. The agarose batch was
filled into column, washed with wash buffer (50 mM NaH2PO4,
300 mM NaCl, 20 mM Imidazole, pH 8.0) and eluted with
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM
Imidazole, PH 8.0). BvTri a 37-containing fractions were pooled
and dialyzed against 10 mM NaH2PO4 pH 8.0 and stored at
220uC.
Characterization of recombinant proteins
The protein concentrations of both recombinant allergens were
determined in parallel by BCA assay (Pierce, Rockford, IL) and
purity was assessed by Coomassie Blue-stained 14% SDS–PAGE.
The protein was analysed under reducing and non-reducing
conditions. [17] Nitrocellulose-blotted, recombinant EcTri a 37
and BvTri a 37 (2 mg each) were tested with serum (dilution 1:10)
from a wheat food allergic patient (Patient 1, Table 1) and buffer
as a control. Bound IgE antibodies were detected with 125I-labeled
anti-human IgE antibodies (Demeditec Diagnostics, Kiel, Ger-
many) and visualized by autoradiography. Aqueous wheat seed
extract (20 mg) was blotted and probed with Tri a 37-specific
rabbit antibodies and for control purposes with the corresponding
pre-immune serum (dilution 1:10.000). Bound IgG antibodies
were detected with 125I-labeled goat anti-rabbit IgG antibodies
(Perkin Elmer, Boston, USA) and visualized by autoradiography.
The identity of the recombinant proteins was confirmed by mass
spectrometry (Bruker, Billerica, MA). [18] Mass spectrometry, size
exclusion chromatography and circular dichroism measurement
(CD) were performed as previously described. [18] For the
chemical crosslinking of oligomers in solution 2 ng of EcTri a 37
or BvTri a 37 were incubated in a total volume of 15 ml with 0.01–
0.2% v/v glutaraldehyde for 15 minutes at room temperature. To
generate samples in a reduced condition 10 mM DTT was added
10 minutes prior to the glutaraldehyde. The reaction was stopped
by adding 2 ml of a 1 M glycine solution. The resulting products
were assessed by 18% SDS-PAGE and by size exclusion
chromatography. [18]
Tri a 37 was analyzed using the Expasy ProtScale accessibility
program for the presence of surface-exposed areas. [19]
Sera from wheat allergic patients used for testing the IgE
reactivity of the allergens
Sera were obtained from European wheat food allergic patients
(Austria n= 1; Finland: n = 3; Greece: n = 6; total: n = 10) aged 3–
41 years (mean age 12 years). Patients were diagnosed on the basis
of a case history demonstrating that allergic symptoms (airway
symptoms, gastrointestinal symptoms, skin symptoms, systemic
anaphylaxis) were unambiguously related to the ingestion of wheat
or wheat-containing products. A grading of symptoms and
definition of anaphylaxis was performed according to the
international position paper and recommendations for the
definition of anaphylaxis (Table 1). [20] In six of the patients,
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open food challenge was performed and positive challenge results
were obtained. Skin prick tests with wheat seed extract were
performed and positive in each of the wheat allergic patients. For
each patient IgE-mediated sensitization to wheat was confirmed by
measurements of allergen-specific IgE (CAP-FEIA, Thermofisher,
Uppsala, Sweden). Patients were further characterized for their
reactivity to the two major wheat food allergens omega-5-gliadin
(Tri a 19) and LMW glutenin (Tri a 36). [21]
Ethical Considerations
Serum samples were obtained in the course of routine allergy
diagnosis with permission of the Helsinki University Hospital
Review Board/Section for Pediatrics (Dnro 374/E7/2004),
Regional Committee of Ethics of the Kopodistrian University of
Athens (289/2007) and the Ethics Committee of the Medical
University of Vienna (565/2007). Written informed consent was
obtained from adult patients and in case of children, from their
parents. A retrospective analysis of allergen-specific IgE antibodies
was performed with anonymized serum samples with permission
of the Ethics Committee of the Medical University of Vienna.
Determination of IgE-reactivity by dot-blotting
IgE-reactivity of EcTri a 37, BvTri a 37 and five peptides (P1–
P5) was tested by by non-denaturing, RAST-based IgE dot
blotting. [15] For dot blotting, aliquots of aqueous wheat seed
extract (2 mg/dot), HSA (0.5 mg/dot), recombinant EcTri a 37,
BvTri a 37 and peptides (0.5 mg/dot) were dotted onto nitrocel-
lulose strips (Schleicher & Schuell, Dassel, Germany). Strips were
incubated with 1:10 diluted sera of allergic patients sera (1–10) or
with 1:10,000 diluted EcTri a 37-specific rabbit antibodies. As a
control, serum of a non-atopic individual (N), rabbit pre-immune
serum or buffer (B) alone were included. Bound IgE antibodies
were detected with 125I-labeled anti-human IgE antibodies
(Demeditec Diagnostics, Kiel, Germany), bound rabbit antibodies
with 125I-labeled anti-rabbit IgG antibodies (Perkin Elmer,
Waltham, USA) and visualized by autoradiography. [22]
Synthesis, characterization and antibody reactivity of Tri
a 37 peptides
Five 10aa- overlapping peptides spanning the Tri a 37 sequence
(Table 2; accession number AFQ60540.1) were synthesized
(Microwave peptide synthesizer liberty CEM GmbH, Germany)
using a Fmoc (9-fluorenylmethoxycarbonyl)-strategy with HBTU
[2-(1H-Benzotriazol-1-yl)1,1,3,3 tetramethyluronium hexafluoro-
phosphat] activation as described by Focke et al. [23] Table 2
shows the amino acid sequences of Tri a 37-derived peptides. Four
of the five peptides had a length of 30 amino acids whereas peptide
4 was synthesized without C-terminal cysteine and hence only 29
aa long. After purification by HPLC to a purity .90%, the
identities of the peptides were confirmed by mass spectrometry.
Inhibition of allergic patients’ IgE-binding to EcTri a 37 by
rabbit IgG antibodies as determined by ELISA inhibition
assay
ELISA plates (Nunc-Immuno Plate, Maxisorp, Thermofisher
Scientific, Denmark) were coated with EcTri a 37 diluted in PBS
(c = 2 mg/ml) overnight at 4uC. After washing plates twice with
PBST and blocking with blocking buffer (PBST, 1% [w/v] BSA)
for 2 hours at room temperature, plates were incubated overnight
at 4uC with rabbit anti-EcTri a 37 immune-serum or the
corresponding pre-immune serum which had been diluted 1:50
in PBST, 0.5% (w/v) BSA. After washing, plates were incubated
with 1:10 diluted sera from wheat food allergic patients (Table 1;
Patients 1, 3, 4) overnight at 4uC and bound human IgE
antibodies were detected with horseradish peroxisase (HRP)-
coupled goat anti-human IgE antibodies (KPL, Gaithersburg,
MD) diluted 1:2,500 in PBST, 0.5% (w/v) BSA. The color
reaction was induced by addition of 1.7 mM 2,29-azino-di-[3-
ethyl-benzthiezolin-sulfonet] (Sigma-Aldrich) in 60 mM citric
acid, 77 mM Na2HPO4?2H2O and 3 mM H2O2.OD measure-
ments were performed after 30 minutes in an ELISA reader
(Spectra Max PLUS 384, Molecular Devices, Germany) at
405 nm-490 nm. The percentage of inhibition of IgE binding
was calculated as follows: 100-(ODimmune/ODpre)x100, where
ODimmune and ODpre represent the extinction coefficients after
pre incubation with the immune serum or with the pre-immune
serum, respectively.
In-vitro digestion assays
Gastric and duodenal in-vitro digestion assay with wheat seed
extract was performed as described. [24,25] Aliquots containing
10 mg undigested or digested extract were loaded on SDS-PAGE
and blotted onto nitrocellulose membranes. Membranes were
incubated either with rabbit Abs raised against EcTri a 37 or the
corresponding pre-immune serum. Bound rabbit Abs were
detected with 125I-labeled anti-rabbit IgG Abs (Perkin Elmer,
Waltham, USA) and visualized by autoradiography.
Results
Expression of recombinant Tri a 37 proteins as unfolded
and folded protein
rTri a 37 expressed in a prokaryotic system using E.coli cells was
designated EcTri a 37, however rTri a 37 expressed in
baculovirus-infected insect cells was termed BvTri a 37. Both
recombinant proteins were purified by Nickel affinity chromatog-
raphy and showed a similar migration behaviour in Coomassie
Blue-stained SDS-PAGE under reducing conditions where they
appeared as bands of approximately 18kDa which differs from
their calculated molecular weights (EcTri a 37 including N-
terminal methionine and C-terminal hexahistine-tag: 12.757 Da;
BvTri a 37 including a D and P residue at the N-terminus and a
C-terminal hexahistidine-tag: 12.838 Da) and may be explained
by the high content of positively charged amino acids (Figure 1A).
Under non-reducing conditions, BvTri a 37 appeared as single
band of approximately 14 kDa whereas EcTri a 37 showed an
additional second band of approximately 18 kDa but no high
molecular weight aggregates were visible in both protein
preparations (Figure 1A). Using serum IgE from a wheat food
allergic patient, monomeric EcTri a 37 and BvTri a 37 were
detected at approximately 18 kDa by immunoblotting. Tri a 37-
specific rabbit antibodies reacted with natural, monomeric Tri a
37 at 15 kDa in a nitrocellulose-blotted aqueous wheat seed
extract (Figure 1B).
MALDI-ToF analysis of EcTri a 37 resulted in a mass peak of
12.742 Da corresponding to the predicted molecular weight of the
monomeric protein including methionine and a hexahistidine-tag.
(Figure 1C, left). Three BvTri a 37 preparations were analyzed by
MALDI-ToF. For one preparation the molecular weight deter-
mined by mass spectrometry (i.e., 11.837 Da) was smaller than the
calculated mass (Figure 1B, right) whereas for the two other
preparations the measured masses were 12.829 Da and
12.913 Da, respectively, which fitted the calculated mass (i.e.,
12.838 Da). The smaller mass of the first preparation was most
likely was due to N-terminal proteolytic degradation because the
His-tag was intact as shown by immunoblotting with an anti-His-
tag antibody (data not shown). Chemical cross-linking experiments
Characterization of Tri a 37
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and size exclusion experiments showed that both, EcTri a 37 and
BvTri a 37, occurred as monomeric proteins (data not shown).
The far-UV CD spectrum of EcTri a 37 indicated that the
recombinant protein was unfolded which is characterized by
minimum at approximately 205 nm. By contrast, BvTri a 37
appeared as folded protein showing a CD spectrum typical for a
predominant a-fold with two minima at 208 and 222 nm and a
maximum at approximately 190 nm (Figure 1D).
Unfolded EcTri a 37 and folded BvTri a 37 show
comparable IgE-reactivity
The IgE-reactivity of both recombinant allergens EcTri a 37
and BvTri a 37 was tested in non-denaturing, RAST-based IgE-
dot blot experiments with sera from 10 patients with confirmed
wheat-induced food allergy (Figure 2A; Table 1). Both allergens
showed very similar and specific IgE-binding capacity when tested
with the sera from the five wheat allergic patients who were
sensitized to Tri a 37 (patients #1–5) but not with sera from wheat
allergic patients who were not sensitized to Tri a 37 (patients #6–
10). Also Tri a 37-specific rabbit antibodies reacted with both
recombinant allergens in a comparable manner (Figure 2A).
Allergic patients’ sera, but not serum from a non-allergic subject
or buffer displayed IgE reactivity to wheat extract. Likewise, wheat
extract was recognized by the rabbit anti-Tri a 37 antibodies but
not by the pre-immune serum or buffer. The negative control
protein HSA showed no reactivity (Figure 2A).
Tri a 37 contains sequential IgE epitopes in the N- as well
as C- terminal domain
In order to study the IgE epitopes of Tri a 37 in more detail, we
tested the sera from the wheat allergic patients also for IgE
reactivity with synthetic Tri a 37 peptides (Figure 2B). Five
overlapping peptides spanning the Tri a 37 sequence were
synthesized and purified (Figure 3, Table 2). With the exception
of peptide 4 which was 29 amino acids long, the synthesized
peptides were 30 amino acids long with overlaps of ten amino
acids (Figure 3A). The molecular weights of the peptides range
from 3095 to 3291 Dalton. Three of the synthesized peptides were
from the original IgE-reactive recombinant fragment whereas
peptides 1 and 2 also included portions of the N-terminal thionin
domain which is rich in basic amino acids and has a pI of 9.75
whereas the C-terminal acidic extension domain is acidic (pI 3.53)
(Figure 3A; Table 2). Hence, the isoelectric points of the
individual peptides ranged from 3.71 to 9.69 depending on the
domain from which they originated (Table 2). Peptides 1, 3 and 4
from both domains were recognized by IgE antibodies from Tri a
37-sensitized patients and also by Tri a 37-specific rabbit
antibodies. Peptides 2 and 5 did not react with IgE from the
tested patients and also not with rabbit IgG antibodies raised by
immunization with rTri a 37 (Figure 2B). According to the
prediction of surface-exposed portions of Tri a 37, the IgE-reactive
peptides were derived from surface-exposed regions (e.g., peptides
3 and 4) but included also less surface-exposed areas (i.e., peptide
1) (Figure 3B).
IgG antibodies induced by immunization with EcTri a 37
recognize similar epitopes as allergic patients IgE and
inhibit allergic patients’ IgE binding to Tri a 37
EcTri a 37- specific rabbit IgG antibodies were then used to
investigate their ability to inhibit wheat food allergic patients’ IgE
binding (Table 1; Patient 1, 3, 4) to the allergen in ELISA
competition experiments. In patients 3 and 4 who showed the
strongest IgE binding to Tri a 37, rabbit anti-Tri a 37 antibodies
caused a 64% and 73% inhibition of IgE binding respectively
whereas the inhibition in patient 1 who showed low levels of Tri a
37-specific IgE was 39% (Figure 4).
Natural Tri a 37 in wheat extracts is digested under
gastric digestion conditions
Figure 5 shows nitrocellulose-blotted wheat extracts which were
subjected to gastric and duodenal digestion and then probed with
rabbit anti-Tri a 37 antibodies. Undigested Tri a 37 was detected
at 15 kDa whereas one minute of gastric digestion led to the loss of
the signal. Under duodenal digestion conditions, Tri a 37 could be
detected even after 45 minutes at 15 kDa and an additional
smaller IgG binding band at 10 kDa became visible after
10 minutes of digestion (Figure 5).
Discussion
Here we showed that IgE recognition of Tri a 37, a wheat food
allergen which is associated with severe wheat-induced anaphy-
Table 2. Characterization of Tri a 37-derived peptides and of the two Tri a 37 domains.
Peptides Sequence Molecular weight Isoelectric point
P1 KSCCRSTLGRNCYNLCRARGAQKLCAGVCR 3291.91 9.69
P2 AQKLCAGVCRCKISSGLSCPKGFPKLALES 3095.75 9.21
P3 KGFPKLALESNSDEPDTIEYCNLGCRSSVC 3276.66 4.51
P4 CNLGCRSSVCDYMVNAAADDEEMKLYVEN 3243.62 4.02
P5 EEMKLYVENCADACVSFCNGDAGLPSLDAY 3228.58 3.71
Thionin domain (45 aa) C-terminal acidic extension domain (65 aa)
basic aa 22.20% 3.10%
acidic aa 0% 22%
pI 9.75 3.35
hydrophobic aa 18% 22%
hydrophilic aa 60% 48%
doi:10.1371/journal.pone.0111483.t002
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laxis does not require conformational epitopes. Using two different
expression systems, an unfolded variant of rTri a 37 (i.e., EcTri a
37) was produced by prokaryotic expression and a folded form was
obtained by expression in baculovirus-infected insect cells (i.e.,
BvTri a 37). The differences in fold between the two recombinant
proteins were not due to differences in glycosylation because Tri a
37 does not contain any glycosylation sites. However, Tri a 37
contains 14 cystein residues of which 8 are known to form 4
disulphide bridges in a correctly folded N-terminal thionin domain
for which the three-dimensional structure was obtained by x-ray
crystallography and nuclear magnetic resonance analysis. [26,27]
Interestingly, both, the folded as well as the unfolded Tri a 37
occurred as monomeric proteins in SDS-PAGE under non-
reducing conditions and when analyzed by size exclusion
chromatography indicating that in both proteins the 14 cysteins
were mainly engaged in the formation of intra-molecular but did
not form inter-molecular disulphide bonds. The presence and lack
of structural fold in the two proteins therefore may be attributed to
correct versus partly incorrect formation of intra-molecular
disulphide bonds. Comparable IgE binding capacity of EcTri a
37 and BvTri a 37 in non-denaturing, RAST-based IgE binding
assay revealed that wheat food allergic patients’ IgE recognition
does not require structural fold of Tri a 37. A more detailed
analysis of IgE epitopes was performed with 5 synthetic peptides
spanning the complete Tri a 37 sequence which had an overlap of
9–10 amino acids. Using these synthetic peptides, sequential IgE
binding sites were found at the N-terminal thionin domain and the
C-terminal extension domain. Not all Tri a 37-reactive sera
reacted also with peptides which may be due to the fact that
certain IgE-reactive areas were not covered by the peptides due to
limited overlap or length. Nevertheless, our data demonstrate that
IgE recognition of Tri a 37 thus does not require fold and is
directed against sequential epitopes which is typical for class I food
allergens which sensitize mainly via the gut such as other wheat
food-, milk, egg and peanut allergens. When we digested natural
wheat extract containing Tri a 37, we found that the allergen was
digested under conditions of gastric digestion whereas it was stable
under conditions of duodenal digestion. This finding fits to the
observation that Tri a 37 contains sequential epitopes which are
represented by peptides. IgE recognition of sequential epitopes
might thus be explained by sensitization to proteolytic fragments of
Tri a 37. In this context it is tempting to speculate that
sensitization to Tri a 37 and symptoms caused by Tri a 37 may
be modulated by conditions affecting gastric digestion such as
pathologies of the gastrointestinal tract and low acidic conditions
Figure 1. Characterization of purified Tri a 37 expressed in E.coli cells (EcTri a 37) and in baculovirus-infected insect cells (BvTri a 37)
as well as detection of natural Tri a 37 in wheat seed extract. (A) Coomassie brilliant blue-stained SDS-PAGE under reducing (lane R) and
under non-reducing (lane NR) conditions. A protein molecular weight marker (kDa) is shown on the left side. (B) Detection of IgE-reactivitiy to
Western-blotted EcTri a 37 and BvTri a 37, using serum from a wheat food allergic patient (P) and buffer (B) as a control. Western-blotted wheat seed
extract was tested with Tri a 37-specific rabbit antibodies (Immune) or the corresponding pre-immune serum (Pre). Bound human IgE and rabbit IgG
antibodies were detected with 125Iodine-labeled antibodies and visualized by autoradiography. Molecular weights are indicated in kilo Dalton (kDa).
(C) Mass spectrometry of recombinant EcTri a 37 and BvTri a 37. The mass/charge ratios are shown on the x-axes, and the intensities are displayed on
the y-axes as percentages of the most intensive signals obtained in the investigated mass range. (D) Circular dichroism analysis of recombinant EcTri
a 37 and BvTri a 37. The spectra are expressed as mean residue ellipticities (h) (y-axes) at given wavelengths (x-axes).
doi:10.1371/journal.pone.0111483.g001
Figure 2. Antibody-recognition of EcTri a 37, BvTri a 37 and Tri a 37 peptides. (A) Nitrocellulose-dotted wheat seed extract (WSE), human
serum albumin (HSA), EcTri a 37 and BvTri a 37 were tested with sera from ten wheat food allergic patients (1–10), with serum from a non-allergic
individual (N), buffer alone (B), with Tri a 37-specific rabbit antibodies (I), the corresponding rabbit pre-immune serum (P) and buffer control (B). (B)
Testing of Tri a 37 peptides (P1–P5) as in (A).
doi:10.1371/journal.pone.0111483.g002
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Figure 3. Localization of synthetic peptides in the Tri a 37 sequence and surface accessibility prediction. (A) Amino acid sequence of Tri
a 37 showing the N- and C-terminal domain and the originally isolated IgE-reactive fragment (underlined). Cysteins are boxed, basic and acidic amino
acids are coloured in red and blue, respectively. Synthetic Tri a 37 peptides P1–P5 are indicated. (B) Surface accessibility plot of the Tri a 37 amino acid
sequence. The numbers of the amino acids, the thionin domain (green), the C-terminal acidic extension domain (pink), the synthetic peptides (yellow)
are indicated on the x-axis. The calculated accessibility of the residues is indicated on the y-axis. Scores above 5.5 (bold horizontal line) represent
regions of high surface accessibility.
doi:10.1371/journal.pone.0111483.g003
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which may occur in in children or elderly persons or as
consequence of antacid medication. [28,29]
Currently several approaches of allergen-specific immunother-
apy are pursued for food allergies, among them oral, sublingual
and epicutaneous immunotherapy with natural food allergens [30]
and also injection immunotherapy approaches using recombinant
food allergens. [31] In this context, we investigated the ability of
rabbit IgG antibodies which were induced by immunization with
recombinant Tri a 37, to inhibit allergic patients IgE binding to
Tri a 37. In fact, we found that Tri a 37-specific IgG inhibited
allergic patients IgE binding to Tri a 37 indicating that it may be
possible to perform injection immunotherapy with recombinant
Tri a 37 with the goal to induce blocking IgG antibodies which are
known to play a major role in immunotherapy.
In conclusion we showed that IgE epitopes of Tri a 37 are of the
non-conformational type, including sequential epitopes and that
rTri a 37 expressed in E.coli as well as insect cells can be used for
the serological detection of Tri a 37-specific IgE in diagnostic tests.
Furthermore, it may be possible to use rTri a 37 for immuno-
therapy in sensitized individuals.
Figure 4. Inhibition of allergic patients’ IgE binding to Tri a 37
by rabbit anti-Tri a 37 antibodies. Tri a 37 was tested for IgE
reactivity with sera from three Tri a 37-allergic patients (1, 3, 4), serum
from a non-allergic individual or buffer after pre-incubation with rabbit
anti-Tri a 37 antibodies (Immune) or the rabbits pre-immune serum
(Pre). Shown are the optical density (O.D.) levels corresponding to
bound IgE.
doi:10.1371/journal.pone.0111483.g004
Figure 5. Effects of gastric and duodenal digestion on natural Tri a 37. Undigested wheat seed extract (undigested) or after different times
of gastric (top panel) or duodenal digestion (lower panel) was subjected to SDS-PAGE and blotted to nitrocellulose. Nitrocelluloses were then tested
with rabbit anti-Tri a 37 antibodies (Immune) and the corresponding pre-immune serum (Pre). Bound IgG antibodies were detected with 125I-labeled
anti-rabbit IgG antibodies and visualized by autoradiography.
doi:10.1371/journal.pone.0111483.g005
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